These findings suggest that IL-37 plays an anti-atherogenic role via a negative regulatory mechanism to dampen the inflammation in atherosclerosis, perhaps by reducing foam cell formation, pro-inflammatory cytokines, as well as macrophage infiltration. This evidence concerns the gene IL37 and atherosclerosis.